Page last updated: 2024-11-02

pilsicainide and Sick Sinus Node Syndrome

pilsicainide has been researched along with Sick Sinus Node Syndrome in 1 studies

pilsicainide: structure given in first source
pilsicainide : A secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker which is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan.

Research Excerpts

ExcerptRelevanceReference
"A single oral dose of pilsicainide, a Class Ic antiarrhythmic drug, is a widely used and highly effective therapy for termination of recent onset atrial fibrillation."8.80Ventricular pacing failure after a single oral dose of pilsicainide in a patient with a permanent pacemaker and paroxysmal atrial fibrillation. ( Abe, H; Kohshi, K; Nagatomo, T; Nakashima, Y; Numata, T, 2000)
"A single oral dose of pilsicainide, a Class Ic antiarrhythmic drug, is a widely used and highly effective therapy for termination of recent onset atrial fibrillation."4.80Ventricular pacing failure after a single oral dose of pilsicainide in a patient with a permanent pacemaker and paroxysmal atrial fibrillation. ( Abe, H; Kohshi, K; Nagatomo, T; Nakashima, Y; Numata, T, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Numata, T1
Abe, H1
Nagatomo, T1
Kohshi, K1
Nakashima, Y1

Reviews

1 review available for pilsicainide and Sick Sinus Node Syndrome

ArticleYear
Ventricular pacing failure after a single oral dose of pilsicainide in a patient with a permanent pacemaker and paroxysmal atrial fibrillation.
    Pacing and clinical electrophysiology : PACE, 2000, Volume: 23, Issue:9

    Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy;

2000